The present invention relates to pharmaceutical formulations comprising at least one jasmonate compound of the family of the jasmonate compounds, combined with a carrier, such as the inclusion compounds, in particular those capable of forming nanoencapsulation or microencapsulation systems. The invention generally relates to inclusion complexes which include jasmonate compounds.